These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 4312765)

  • 21. [Duration of the after-control of the tuberculous patients following the termination of the treatment].
    Neumann G
    Wien Med Wochenschr; 1972 Dec; 122(51):764-8. PubMed ID: 4346497
    [No Abstract]   [Full Text] [Related]  

  • 22. Chemotherapy of tuberculosis.
    Lester W
    Clin Notes Respir Dis; 1970; 9(2):3-13. PubMed ID: 4319281
    [No Abstract]   [Full Text] [Related]  

  • 23. Cycloserine plus ethionamide plus pyrazinamide in the treatment of patients excreting isoniazid-resistant tubercle bacilli following previous chemotherapy.
    Ramakrishnan CV; Parthasarathy R; Sambamoorthy S; Somasundaram PR; Subbammal S
    Indian J Med Res; 1976 Jan; 64(1):76-82. PubMed ID: 818010
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparison of ethionamide-cycloserine and ethionamide-pyrazinamide regimens in patients resistant to major chemotherapeutics.
    Vidinel I
    Scand J Respir Dis Suppl; 1970; 71():192-5. PubMed ID: 5271985
    [No Abstract]   [Full Text] [Related]  

  • 25. [Triple reserved scheme in the treatment of resistent forms of pulmonary tuberculosis (preliminary results)].
    Rizzo A; Magalhães M; Moura N
    Rev Bras Med; 1969 Sep; 26(9):504-10. PubMed ID: 5381888
    [No Abstract]   [Full Text] [Related]  

  • 26. Newer and second-line drugs in the treatment of drug-resistant tuberculosis in children.
    Steiner M
    Med Clin North Am; 1967 Sep; 51(5):1153-67. PubMed ID: 4297572
    [No Abstract]   [Full Text] [Related]  

  • 27. [The treatment of urogenital tuberculosis with current drugs].
    König K; May P
    Urologe; 1968; 7(1):23-9. PubMed ID: 4297580
    [No Abstract]   [Full Text] [Related]  

  • 28. [Results of treatment of pulmonary tuberculosis in adults with second line drugs].
    Ropek M; Szymański A; Chetkowski A; Tarocińska B
    Gruzlica; 1968 Oct; 36(10):1043-6. PubMed ID: 5710086
    [No Abstract]   [Full Text] [Related]  

  • 29. Experience with cycloserine.
    Dissmann E
    Scand J Respir Dis Suppl; 1970; 71():239-43. PubMed ID: 5317744
    [No Abstract]   [Full Text] [Related]  

  • 30. [Combination of ethambutol with ethionamide, cycloserine and-or pyrazynamide in retreatment of pulmonary tuberculosis].
    Kekkaku; 1968 Feb; 43(2):91-5. PubMed ID: 5678013
    [No Abstract]   [Full Text] [Related]  

  • 31. [The results of treatment with minor drugs, i.e. kanamycin, ethionamide and cycloserine, for severe pulmonary tuberculosis patients discharging bacilli resistant to all the three major drugs].
    Matsumoto M; Izumi K; Kamima H; Hirose H; Saito M
    Kekkaku; 1966 Jan; 41(1):39-46. PubMed ID: 5962711
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of drugs of secondary group in complex therapy of children with chronic tuberculosis].
    Rushchak VA
    Pediatr Akus Ginekol; 1971; 2():24-5. PubMed ID: 4254375
    [No Abstract]   [Full Text] [Related]  

  • 33. [Secondary antitubercular drugs in the treatment of childhood tuberculosis].
    de Lacerda A
    Rev Port Pediatr Pueric; 1967 May; 30(5):149-56. PubMed ID: 4303078
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment with new antitubercular agents].
    Gartmann J
    Dtsch Med Wochenschr; 1968 Nov; 93(47):2281-2. PubMed ID: 4301079
    [No Abstract]   [Full Text] [Related]  

  • 35. The first clinical experiences with ethambutol in chronic pulmonary tuberculosis and basilar meningitis.
    Krivinka R; Tousek J
    Antibiot Chemother; 1970; 16():215-21. PubMed ID: 4108889
    [No Abstract]   [Full Text] [Related]  

  • 36. Therapeutic effect of minor antituberculosis drugs on advanced pulmonary tuberculosis.
    Ando M
    Nagoya J Med Sci; 1967 Jan; 29(3):261-70. PubMed ID: 6074943
    [No Abstract]   [Full Text] [Related]  

  • 37. [Autonomous treatment of pulmonary tuberculosis with delayed-action drugs].
    Pannain M; Tarantino AB; Mac Dowell A; Costa JA; Cunha JM; Pantoja W
    Rev Bras Med; 1967 Aug; 24(8):664-8. PubMed ID: 5603007
    [No Abstract]   [Full Text] [Related]  

  • 38. [Tuberculostatics of the second order (relay drugs). Their share in combined therapy of pulmonary tuberculosis].
    Naegeli HR
    Schweiz Med Wochenschr; 1966 Apr; 96(15):495-500. PubMed ID: 4293638
    [No Abstract]   [Full Text] [Related]  

  • 39. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis].
    Utkin VV; Rudoĭ NM
    Klin Med (Mosk); 1968 Dec; 46(12):36-43. PubMed ID: 5737381
    [No Abstract]   [Full Text] [Related]  

  • 40. [On qualitative demonstration of tuberculostatics in the control of taking of drugs].
    Grunert M; Reutgen H; Iwainsky H
    Z Tuberk Erkr Thoraxorg; 1965; 124(3):141-8. PubMed ID: 5899136
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.